Seres Therapeutics, Inc. (MCRB) Net income 2016–2025
Seres Therapeutics, Inc. (MCRB) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$5.7MFY2025 · since FY2016: -$91.6M → $5.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.7M | +4088.2% |
| FY2024 | $136,000 | +100.1% |
| FY2023 | -$113.7M | +54.5% |
| FY2022 | -$250.2M | -281.5% |
| FY2021 | -$65.6M | +26.4% |
| FY2020 | -$89.1M | -26.8% |
| FY2019 | -$70.3M | +29.0% |
| FY2018 | -$98.9M | -10.7% |
| FY2017 | -$89.4M | +2.4% |
| FY2016 | -$91.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice